Please join us at theJoint Conference of European Human Pharmacological Societies CLUB PHASE I (France), AGAH (Germany), BAPU (Belgium), AHPPI (UK)11 & 12 April 2013Nice Sophia Antipolis, FranceThe meeting will focus on Early Clinical Utility Assessment of new medicines and how early development should be conducted to optimize the challenging process of reaching efficient and early go/no go decisions.Be part of this European meeting featuring first class plenary sessions and interactive workshops and experience excellent networking opportunities in stimulating surroundings.View programmeRegister online

Please forward this invitation to interested colleagues also.Looking forward to seeing you!Sincerely yoursConference ChairDr. Yves DonazzoloPresident CLUB PHASE IIntercom Kongresse GmbHAntje BlmekeEppendorfer Baum 39a20249 Hamburg (Germany)Phone: +49 40 480610 61Telefax: +49 40 480610 66E-Mail: abloemeke@intercom.deWeb: www.intercom..de

Disclaimer 2013 Intercom Kongresse GmbHEppendorfer Baum 39a, 20249 Hamburg/GermanyUSt-ID DE 1615 400 24, Registry court Hamburg, HRB 113503. All rights reserved. Responsible for contents pursuant to 6 MDStV Managing Director Alexandra Werner.

Latest news

Richmond promotes new Director of Communications and Participant Engagement

August 12, 2024
Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and Participant Engagement.
Read more

Richmond Chief Medical Director calls for a ‘toolbox’ of standards and guidelines for clinical trials

August 5, 2024
The British Journal of Clinical Pharmacology has published an editorial by Richmond’s Dr Ulrike Lorch and Professor Charles Vincent of Oxford University calling for a ‘toolbox’ of practical standards and guidelines for early phase clinical trials.
Read more

Events

Pulse Virtual: Respiratory, CVD, Diabetes and Nutrition

Wednesday 18th September
Richmond will be presenting at the upcoming Pulse Virtual Event aimed at GPs
View event